Fractus Takes Legal Action Against ResMed for Patent Infringement in California

Fractus Initiates Legal Proceedings Against ResMed

In a significant development, Fractus, a leading innovator in geometry-based antenna technology, has officially filed a lawsuit against ResMed in the United States District Court for the Southern District of California. This legal action revolves around allegations of patent infringement concerning ResMed’s sleep apnea devices and related therapy solutions. Fractus asserts that these products violate several of its patents, which focus on miniaturized and high-performance multi-band antenna innovations.

Jordi Ilario, the CEO of Fractus, stated, "Fractus has invested decades in research that allows for reliable and compact wireless connectivity across various industries. When companies make use of our patented technology without permission, we take action to defend our intellectual property rights and ensure a fair environment for innovators who respect those rights."

Ruben Bonet, Executive Chairman of Fractus, emphasized the growing importance of connectivity in digital health and remote patient monitoring. He noted, "Our goal is to protect the value of our inventions, enabling technology leaders to build on established and fairly licensed foundations."

The law firm Kobre & Kim LLP is representing Fractus in this legal battle. The case will be led by experienced trial lawyers Michael Ng, Daniel Zaheer, and George Stamatopoulos, who specialize in intellectual property disputes. Michael Ng remarked, "We are excited to work with Fractus again to ensure that the value of its pioneering innovations is recognized. These inventions have positively impacted global health standards."

Fractus stands out as an early pioneer in the use of advanced mathematics and geometry to advance antenna design. The patents held by Fractus allow for compact, high-performance, multi-band antennas, which are crucial in devices like smartphones, IoT products, and connected healthcare applications. The company is proud to hold a robust portfolio of over 40 patented inventions, and its technology has been licensed by many notable global companies.

Fractus’s reputation in the industry is underscored by various accolades, including recognition as a 2005 World Economic Forum Technology Pioneer and finalist placements in the 2014 European Inventor Award. Additionally, in 2017, Fractus received the "European Inspiring Company Award" from the London Stock Exchange Group.

As this lawsuit unfolds, industry observers will be keen to monitor the implications for both Fractus and ResMed, as well as the broader landscape of patent rights within technology and healthcare. Fractus remains committed to advocating for rigorous protection of its intellectual properties to foster continued innovation and development in the field.

In conclusion, the filing of this lawsuit not only underscores Fractus's dedication to protecting its significant technological developments but also highlights the ongoing challenges companies face when it comes to intellectual property rights in the competitive landscape of health and technology.